↓ Skip to main content

Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma

Overview of attention for article published in Frontiers in immunology, October 2021
Altmetric Badge

Mentioned by

twitter
2 X users

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma
Published in
Frontiers in immunology, October 2021
DOI 10.3389/fimmu.2021.778459
Pubmed ID
Authors

Jenny Bulgarelli, Claudia Piccinini, Elisabetta Petracci, Elena Pancisi, Anna Maria Granato, Francesco de Rosa, Massimo Guidoboni, Massimiliano Petrini, Valentina Ancarani, Giovanni Foschi, Antonino Romeo, Luca Tontini, Ugo De Giorgi, Cristian Lolli, Giorgia Gentili, Linda Valmorri, Alice Rossi, Fabio Ferroni, Carla Casadei, Pietro Cortesi, Laura Crudi, Laura Ridolfi

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 17%
Researcher 3 13%
Student > Bachelor 2 9%
Student > Ph. D. Student 1 4%
Lecturer 1 4%
Other 1 4%
Unknown 11 48%
Readers by discipline Count As %
Medicine and Dentistry 5 22%
Immunology and Microbiology 2 9%
Nursing and Health Professions 2 9%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Sports and Recreations 1 4%
Other 1 4%
Unknown 11 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 November 2021.
All research outputs
#20,669,432
of 25,392,582 outputs
Outputs from Frontiers in immunology
#24,766
of 31,541 outputs
Outputs of similar age
#332,355
of 443,124 outputs
Outputs of similar age from Frontiers in immunology
#1,199
of 1,493 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 31,541 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 443,124 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,493 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.